companydata.dkcompanydata.dk

FLUIMEDIX ApS: Financial statements 2025

CVR: 27021689

Source: annual report 2025, Danish Business Authority

01/01/202531/12/2025

FLUIMEDIX ApS (CVR 27021689) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,224 and a net result of DKK 17,955 compared with DKK -64,901 the year before. Equity in the 2025 report amounted to DKK 255,826. The solvency ratio was 77.7%. The company had 1 employee in the financial year.

Gross Profit
DKK 12,224
Profit/Loss
DKK 17,955
Equity
DKK 255,826
Total Assets
DKK 329,284
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-12 t.18 t.256 t.1
2024--56 t.-65 t.238 t.1
2023-244 t.-81 t.303 t.1
2022--89 t.-364 t.383 t.1
2021--1 t.-279 t.747 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is FLUIMEDIX ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

FLUIMEDIX ApS: The 2024 annual report is outJul 8, 2025

FLUIMEDIX ApS has published its annual report for 2024. Gross profit came to DKK -56,321, and the net result was DKK -64,901.

About FLUIMEDIX ApS

FLUIMEDIX ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2003. The company is registered under the industry Anden teknisk rådgivning. The management consists of Tomas Ussing. The board consists of Rolf Bertil Ehrnström, Rolf Singer, Sissel Mygind Trap and Steen Hansen. The company is owned by OPFINDER HOLDING AF 2003 ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 12,224 and a net result of DKK 17,955 compared with DKK -64,901 the year before. Equity in the 2025 report amounted to DKK 255,826.

Source: annual report 2025, Danish Business Authority